Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer. Laine M, Fanning SW, Chang YF, Green B, et al. Breast Cancer Res 2021;23:54.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Laine M, Fanning SW, Chang YF, Green B, et al. Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer. Breast Cancer Res 2021;23:54.
PMID: 33980285